Bangladesh s Main Opposition to Boycott Vote if Hasina Stays Put usnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usnews.com Daily Mail and Mail on Sunday newspapers.
India's Uttar Pradesh state on Thursday said Marion Biotech, whose cough syrups Uzbekistan linked to the deaths of 65 children last year, will have to file a report of "corrective and preventive action" before being allowed to reopen its factory. It said the company could resume production and sale of items that do not contain an ingredient linked to the cough syrup deaths, but did not give a timeline for resumption of production. The drug controller, Shashi Mohan Gupta, said in the statement that the article was misleading and that the Uttar Pradesh government had asked Marion to file a report of Corrective and Preventive Action (CAPA) to address its shortcomings.
Marion Biotech, the Indian pharmaceutical company whose cough syrups were linked to the deaths of 65 children in Uzbekistan last year, will have to submit a report of "corrective and preventive action" before being allowed to reopen its factory in Uttar Pradesh. The state s drug controller stated that the company could resume production and sale of items that do not contain the ingredient linked to the deaths, but did not give a timeline for resumption.
India s northern state of
Uttar Pradesh has permitted the resumption of most production at
a factory owned by Marion Biotech, which produced cough syrups
Uzbekistan linked to the deaths of 65 children. -October 11, 2023 at 03:13 am EDT
- MarketScreener
India's northern state of Uttar Pradesh has permitted the resumption of most production at a factory owned by Marion Biotech, which produced cough syrups Uzbekistan linked to the deaths of 65 children last year, an order seen by Reuters shows. The firm is among three Indian companies whose cough syrups the World Health Organization (WHO) and other agencies have linked to the deaths of 141 children in Uzbekistan, Gambia and Cameroon, in one of the world's worst such waves of poisoning. "There is no known case of a lack of quality in other medicines manufactured by the firm," the drug controller of the state where Marion is based, and which cancelled the firm's licence in March, said in the most recent order.